Publicaciones en las que colabora con FRANCISCO JOSE DASI FERNANDEZ (6)

2017

  1. Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma

    OncoTargets and Therapy, Vol. 10, pp. 503-514

2012

  1. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics

    PLoS ONE, Vol. 7, Núm. 8

  2. Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients

    Expert Opinion on Biological Therapy

2007

  1. Pig liver gene therapy by noninvasive interventionist catheterism

    Gene Therapy, Vol. 14, Núm. 4, pp. 334-343

2006

  1. Antigens and cytokine genes in antitumor vaccines: The importance of the temporal delivery sequence in antitumor signals

    Annals of the New York Academy of Sciences

2005

  1. Cytokine expression and dendritic cell density in melanoma sentinel nodes

    Melanoma Research, Vol. 15, Núm. 2, pp. 99-106